Novartis CEO Touts R&D 'Wild Cards' As Proof Of Deep Pipeline

Multi-Billion Dollar Opportunities In Development

 
• By Kevin Grogan
  
poker
Novartis reveals strong hand in R&D • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D